Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

11.66
BATS BZX Real-Time Price
As of 3:25pm ET
 -0.13 / -1.10%
Today’s Change
8.67
Today|||52-Week Range
14.15
+8.97%
Year-to-Date

Today’s Trading

Previous close11.79
Today’s open11.72
Day’s range11.51 - 11.72
Volume36,757
Average volume (3 months)933,915
Market cap$1.3B
Dividend yield--
Data as of 3:25pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+142.77%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+97.09%
P/E ratio33.1
Price/Sales9.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.65-2.51%
EBSEmergent BioSolution...-0.03-0.10%
AXONAxovant Sciences Ltd-0.01-0.08%
DERMDermira Inc+0.05+0.15%
Data as of 3:26pm ET, 02/22/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$133.6M
Annual profit (last year)$59.5M
Net profit margin44.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs